Australia is witnessing a significant surge in cancer diagnoses, leading to an increased demand for advanced oncology devices. This trend underscores the critical need for innovative medical technologies to enhance cancer detection, treatment, and patient outcomes across the nation.Rising Cancer Incidence in AustraliaRecent data from
Commitment to stringent European standards reinforces Venus Remedies’ leadership in antibiotics and oncology manufacturing while positioning the company for continued growth in global markets Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a premier player in the global pharmaceutical industry, has announced the successful renewal of its
HCG Aastha Cancer Centre organised “Her Hope,” a community-driven initiative featuring a powerful physical theatre performance to raise awareness about cervical cancer, its prevention, and the importance of early detection. Centered on the empowering theme “Prevention is Power,” the event used expressive storytelling to convey
Advancement in Thoracic Surgery Marks a New Era in Patient CareAll India Institute of Medical Sciences (AIIMS), Nagpur, has successfully performed a complex lung surgery on a patient diagnosed with a rare form of lung cancer. This achievement underscores the institute's commitment to providing cutting-edge
Neuberg Diagnostics, founded in 2017 and headquartered in Chennai, has rapidly emerged as the fastest-growing, largest integrated diagnostics player in the country and one of the top 4 largest diagnostics providers of Indian origin. With an extensive network spanning over 10,000 touch points and 250+
Hyderabad to Host Southeast Asia's First DynamicARC Proton Therapy SystemAIG Hospitals, a leading multispecialty healthcare institution, has unveiled plans to invest ₹800 crore in establishing a dedicated oncology centre at its Gachibowli campus in Hyderabad. This significant investment underscores the hospital's commitment to advancing cancer
The Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI) has announced the development of a groundbreaking and cost-effective treatment for gallbladder cancer, offering improved outcomes for patients. This advancement is particularly significant for regions like northern India, where gallbladder cancer prevalence is notably high.The innovative
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026 Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone by receiving Good Manufacturing Practices (GMP) certification from
Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND) and Innovent Biologics have announced a groundbreaking partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient
Dr. Kinjal Jani, Director and Head - Radiation Oncology, HCG Cancer Centre, AhmedabadIn today's medical innovation world, the science behind healthcare is evolving continuously, and cancer treatment isn't an exception to it. Prostate cancer—the deadliest disease among millions of men around the globe- now has
